Detalles de la búsqueda
1.
Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage.
Stroke
; 51(4): 1142-1149, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32138631
2.
Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)].
Neurocrit Care
; 30(1): 88-97, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30014184
3.
Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage]).
Stroke
; 48(1): 145-151, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27932607
4.
NEWTON: Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage.
Neurocrit Care
; 23(2): 274-84, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25678453
5.
Nimodipine pharmacokinetics after intraventricular injection of sustained-release nimodipine for subarachnoid hemorrhage.
J Neurosurg
; 134(1): 95-101, 2019 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31812149
6.
A Site-Specific, Sustained-Release Drug Delivery System for Aneurysmal Subarachnoid Hemorrhage.
Neurotherapeutics
; 13(2): 439-49, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26935204
Resultados
1 -
6
de 6
1
Próxima >
>>